Motor learning impairments are a hallmark of basal ganglia disorders, severely affecting gait, postural stability, and overall physiotherapy outcomes. First, we will explore the integration of neuroplasticity-promoting treatments with targeted physiotherapy. This session focuses on advancing physiotherapy strategies for movement disorders, particularly Parkinson’s Disease (PD) and parkisnonism, by exploring the interplay between neuroplasticity, innovative technologies, and the precise timing of interventions.  The discussion will focus on optimizing physiotherapy strategies by addressing individual variability in responses and disease characteristics. The objective is to improve motor function, facilitate behavior change, and enhance the quality of life for individuals with PD.

 

In addition, technological advancements offer new avenues for monitoring and enhancing physiotherapy outcomes in movement disorders. We will examine how integrating technology into rehabilitation plans can personalize interventions, addressing the variability in disease progression and treatment responses. The focus will be on leveraging real-time monitoring tools and outcome measurements to tailor rehabilitation to individual patient needs, ultimately optimizing therapeutic outcomes and stimulating behavior changes in individuals with movement disorders.

 

Finally, we will discuss the physiotherapy time, intensity, and dosing are crucial for improving functional outcomes in PD, particularly in managing freezing of gait and reducing fall risks. This session will provide evidence-based, emphasizing the importance of early intervention and novel techniques. The goal is to equip participants with actionable insights on prescribing and implementing effective gait rehabilitation programs that cater to the disease’s progression and variability.